Analysis of Existing Problems of Proprietary Chinese Medicines in 2018 Edition of the National Essential Medicines List

Fu Zhihui, Shi Yamin, Zhang Xiaochuan, Zhou Zheng, Jia Wenrui, Zhu Chunsheng, Nie Anzheng

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (8) : 892-898.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (8) : 892-898. DOI: 10.16153/j.1002-7777.2021.08.007
Supervision Administration

Analysis of Existing Problems of Proprietary Chinese Medicines in 2018 Edition of the National Essential Medicines List

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(8): 892-898 https://doi.org/10.16153/j.1002-7777.2021.08.007

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉